Shareholder group calls on UnitedHealth to decouple CEO from board chair

Group 1 - UnitedHealth is currently facing significant challenges, including a major cyberattack, rising medical expenses affecting profitability, and federal antitrust investigations [3][4] - The company's stock has decreased by 29% this year, reflecting investor concerns despite its record revenue of $400.3 billion last year [4][5] - Stephen Hemsley has been appointed as CEO following Andrew Witty's resignation, which some analysts believe may restore confidence in the company [5][6] Group 2 - An activist investor group, the Accountability Board, is advocating for a separation of the CEO and board chair roles to enhance oversight during this turbulent period [7][9] - The Accountability Board criticized the rationale for combining these roles as "deeply flawed," indicating a need for improved governance [8][9] - UnitedHealth has not commented on the proposal from the Accountability Board [9]